Targeting lentiviral vectors to antigen-specific immunoglobulins.
about
Engineering fusogenic molecules to achieve targeted transduction of enveloped lentiviral vectorsCell-specific targeting of lentiviral vectors mediated by fusion proteins derived from Sindbis virus, vesicular stomatitis virus, or avian sarcoma/leukosis virus.Selective viral vector transduction of ErbB4 expressing cortical interneurons in vivo with a viral receptor-ligand bridge protein.Library screening and receptor-directed targeting of gammaretroviral vectors.Immunization delivered by lentiviral vectors for cancer and infectious diseases.Preferential lentiviral targeting of astrocytes in the central nervous system.Pseudotyping lentiviral vectors with aura virus envelope glycoproteins for DC-SIGN-mediated transduction of dendritic cells.Engineered lentiviral vectors pseudotyped with a CD4 receptor and a fusogenic protein can target cells expressing HIV-1 envelope proteins.Development of the Nanobody display technology to target lentiviral vectors to antigen-presenting cells.Lentiviral delivery of short hairpin RNAsLentiviral vectors for immune cells targeting.Recent advances in lentiviral vector development and applications.Advances in the field of lentivector-based transduction of T and B lymphocytes for gene therapy.Inhibition of the p53-MDM2 interaction by adenovirus delivery of ribosomal protein L23 stabilizes p53 and induces cell cycle arrest and apoptosis in gastric cancer.Immune Modulatory Cell Therapy for Hemophilia B Based on CD20-Targeted Lentiviral Gene Transfer to Primary B Cells.Genetic Modification of T Cells.Surface-Engineered Lentiviral Vectors for Selective Gene Transfer into Subtypes of Lymphocytes
P2860
Q27488806-B94DACF5-F050-4CE2-BCE2-E37D2A3A626FQ33663063-22FF7B84-F7BB-4301-AF51-A3C0D5BECF34Q34151811-7A33EC90-8A44-420B-897D-4D24B0BFE3D7Q34517833-75B2989C-2B82-489F-83FD-9EAEE5818493Q34539879-A03FB18E-39D9-4582-9D9F-A4839911D4DCQ35009241-95C77570-763F-4AEA-9C8D-25CF2982E2A7Q35496414-F6FE2814-7BDE-4851-9753-66F7B29E7FD2Q36390352-C4B96C9A-3853-4750-9415-2EFB73F56F2CQ36460535-F6E1C8A5-A678-4321-A82A-6E25AE53F424Q37430557-CE8BE6E6-52C5-404C-8A69-B0160E3105E3Q37677792-7859E214-336C-4446-A3B9-8C8952464531Q37678176-5D8B6AFB-4ECA-49DB-99B6-C84ACCEC47F0Q37782256-C3EE40FB-A59E-421C-A23D-51F00B8A2863Q39761661-28488992-9F1F-4F5E-820E-1D369A69D855Q40211579-BD7D083C-DF0B-4BB1-BB27-EC6F94142CB0Q54385319-AAACFDA8-DFD3-4EAF-BD07-22F69A73049BQ58726929-B4AF4C41-96A9-4BD8-8469-A2CDC7259402
P2860
Targeting lentiviral vectors to antigen-specific immunoglobulins.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Targeting lentiviral vectors to antigen-specific immunoglobulins.
@en
Targeting lentiviral vectors to antigen-specific immunoglobulins.
@nl
type
label
Targeting lentiviral vectors to antigen-specific immunoglobulins.
@en
Targeting lentiviral vectors to antigen-specific immunoglobulins.
@nl
prefLabel
Targeting lentiviral vectors to antigen-specific immunoglobulins.
@en
Targeting lentiviral vectors to antigen-specific immunoglobulins.
@nl
P2093
P2860
P356
P1433
P1476
Targeting lentiviral vectors to antigen-specific immunoglobulins.
@en
P2093
David Baltimore
Haiguang Yang
Kye il Joo
Leslie Ziegler
P2860
P304
P356
10.1089/HUM.2007.149
P577
2008-09-01T00:00:00Z